New York, June 20, 2014 -- Moody's Investors Service commented that the disclosed offer by AbbVie Inc. ("AbbVie") to merge with Shire PLC for approximately $46.5 billion is overall credit negative as it would raise AbbVie's financial leverage. At the same time, the deal would have positive benefits to AbbVie's business profile. AbbVie is rated Baa1 with a positive outlook, and there is no change to AbbVie's rating or outlook at this time.
Vollständigen Artikel bei Moodys lesen
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.